- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04714463
Effects of Expectations and Body Image in Breast Reconstruction
June 30, 2025 updated by: Vastra Gotaland Region
Psychological Effect of Expectations and Body Image on Outcomes of Breast Reconstruction
A breast reconstruction after mastectomy, either due to breast cancer or a high lifetime risk for cancer, is performed to increase the patient's quality of life.
However, there are studies that show that some women regret their decision to have breast reconstruction.
There are also studies demonstrating similarities in the general patterns of psychosocial adjustment and quality of life among women with breast cancer who have undergone breast-conserving surgery, mastectomy alone, and mastectomy combined with breast reconstruction.
Hence, it is unclear which women actually benefit from a breast reconstruction.
The concept of quality of life is connected to patient satisfaction and body image/investment.
Therefore, the aim of this project is to examine the effects of patient expectations and body image on the patient reported outcomes of breast reconstruction, to improve preoperative information and postoperative care for women considering a breast reconstruction.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emma Hansson, PhD
- Phone Number: +46313421000
- Email: emma.em.hansson@vgregion.se
Study Locations
-
-
-
Gothenburg, Sweden, 413 45
- Recruiting
- Sahlgrenska University Hospital
-
Contact:
- Linn Weick, MA
- Phone Number: +46 31 342 10 00
- Email: linn.weick@vgregion.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Biological women with breast cancer or high risk for breast cancer who want immediate or delayed post-mastectomy breast reconstruction.
Description
Inclusion Criteria:
- Biological women with breast cancer or high risk for breast cancer who want post-mastectomy breast reconstruction
- Age > 18 years
Exclusion Criteria:
- Inability to give informed consent
- Inability to understand Swedish
- Relaps of cancer
- Palliative treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Immediate breast reconstruction
Women undergoing immediate breast reconstruction due to breast cancer or a high risk for breast cancer
|
All types of implant based breast reconstructions
All types of autologous breast reconstructions
All types of breast reconstructions combining autologous and implant based techniques
|
|
Delayed breast reconstruction
Women undergoing delayed breast reconstruction due to breast cancer or a high risk for breast cancer
|
All types of implant based breast reconstructions
All types of autologous breast reconstructions
All types of breast reconstructions combining autologous and implant based techniques
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction with breast reconstruction measured with Breast Q reconstruction
Time Frame: 2 years
|
Breast Q reconstruction includes two domains and six different modules: health-related quality of life (HR-QOL; including physical, psychosocial, and sexual well-being) and patient satisfaction (including satisfaction with breasts, outcome, and care).
Each scale produces an independent score from 0-100.
A higher score means greater satisfaction or better QOL.
|
2 years
|
|
Patient expectations measured with Breast Q expectations
Time Frame: 2 years
|
Breast Q expectations.The scale consists of five modules: expectations for support from medical staff , expectations for pain, expectations for coping, expectations for breast appearance when clothed and expectations for breast sensation.
The score for each independent scale range from 0-100.
A higher score means greater expectations.
|
2 years
|
|
Body image measured with Multidimensional body-self relations questionnaire- appearance scales (MBSRQ-AS)
Time Frame: 2 years
|
MBSRQ-AS - Multidimensional body-self relations questionnaire- appearance scales.It is a 34-item self-report questionnaire designed to measure appearance related components of body-image.
In consists of five subscales: appearance evaluation, appearance orientation, body areas satisfaction, overweight preoccupation, and self-classified weight.
It is a 5-point Likert-scale ranging from 1 to 5.
|
2 years
|
|
Body image investment measured with Appearance schemas inventory-revised (ASI-R)
Time Frame: 2 years
|
ASI-R - Appearance schemas inventory-revised: is a 20-item self-report questionnaire designed to measure body-image investment.
It consists of two subscales, self-evaluative salience (SES) and motivational salience (MS).
It is a 5-point Likert-scale ranging from 1 (strongly disagree) to 5 (strongly agree).
Twelve items relate to SES and eight items relate to MS.
The total score is the mean of the 20 items, and the score of the subscales is the mean of the items relating to each subscale.
A high score indicates greater body-image investment.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction with preoperative information measured with Breast Q reconstruction
Time Frame: 2 years
|
Measured with one of the sub scales of Breast Q reconstruction
|
2 years
|
|
Pain measured with a visual analogue scale
Time Frame: 2 weeks
|
Measured with a post-operative pain dairy with VAS scales (o means no pain and 10 means the worst possible pain imaginable)
|
2 weeks
|
|
Sick leave according to authorities
Time Frame: 1 year
|
Actual sick leave according to the Swedish authorities
|
1 year
|
|
Number of out-patient visits according to the medical charts
Time Frame: 1 year
|
Actual number of out-patient visits, according to the medical chart
|
1 year
|
|
Depression and anxiety measured with Hospital Anxiety and Depression Scale (HADS)
Time Frame: 2 years
|
HADS - Hospital Anxiety and Depression Scale: is a 14-item self-report questionnaire that is designed to measure anxiety and depression.
It has two domains, where seven items relate to anxiety and seven relate to depression.
It is a 4-point Likert-scale ranging from 0-3.
Each domain has a maximum score of 21.
For both domains, scores of less than 7 indicate non-cases, whereas scores of 8-10 indicate mild anxiety or depression, 11-14 moderate and 15-21 severe.
|
2 years
|
|
Demographic factors and medical factors according to medical charts
Time Frame: 2 years
|
Demographic factors that might affect expectations and satisfaction, such as age, comorbidity, and previous cosmetic breast surgery, and medical factors such as timing of reconstructions, reason for mastectomy, type of cancer and cancer treatment received.
|
2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Translation and validation of Breast-Q expectations
Time Frame: 4 months
|
Translation into Swedish according to MAPI-guidelines.
Validation of psychometric properties in a Swedish population.The scale consists of five modules: expectations for support from medical staff , expectations for pain, expectations for coping, expectations for breast appearance when clothed and expectations for breast sensation.
The score for each independent scale range from 0-100.
A higher score means greater expectations.
|
4 months
|
|
Translation and validation of Appearance schemas inventory-revised (ASI-R)
Time Frame: 4 months
|
Translation into Swedish according to MAPI-guidelines.
Validation of psychometric properties in a Swedish population.
ASI-Ris a 20-item self-report questionnaire designed to measure body-image investment.
It consists of two subscales, self-evaluative salience (SES) and motivational salience (MS).
It is a 5-point Likert-scale ranging from 1 (strongly disagree) to 5 (strongly agree).
Twelve items relate to SES and eight items relate to MS.
The total score is the mean of the 20 items, and the score of the subscales is the mean of the items relating to each subscale.
A high score indicates greater body-image investment.
|
4 months
|
|
Translation and validation of Multidimensional body-self relations questionnaire- appearance scales (MBSRQ-AS)
Time Frame: 4 months
|
Translation into Swedish according to MAPI-guidelines.
Validation of psychometric properties in a Swedish population.Multidimensional body-self relations questionnaire- appearance scales.It is a 34-item self-report questionnaire designed to measure appearance related components of body-image.
In consists of five subscales: appearance evaluation, appearance orientation, body areas satisfaction, overweight preoccupation, and self-classified weight.
It is a 5-point Likert-scale ranging from 1 to 5.
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Emma Hansson, PhD, Göteborg University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2021
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
January 12, 2021
First Submitted That Met QC Criteria
January 14, 2021
First Posted (Actual)
January 19, 2021
Study Record Updates
Last Update Posted (Actual)
July 3, 2025
Last Update Submitted That Met QC Criteria
June 30, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 2020-06245
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Implant-based breast reconstruction
-
Branch Office of "Hadassah Medical Ltd"Federal Research Clinical Center of Federal Medical & Biological Agency,...RecruitingBreast Cancer Stage I | Breast Cancer Stage II | In Situ Breast CancerRussian Federation
-
Vastra Gotaland RegionRecruitingBreast Cancer | Weight Loss | Breast Reconstruction | Surgical Complication | Bariatric Surgery | Breast Implant Infection | Breast Implant | MastopexySweden
-
University of OxfordNational Institute for Health Research, United KingdomEnrolling by invitationBreast Cancer | Risk ReductionUnited Kingdom
-
Ottawa Hospital Research InstituteRecruitingBreast Cancer | MastectomyCanada
-
The Leeds Teaching Hospitals NHS TrustRecruitingBreast Cancer | Surgery | Patient Satisfaction | Breast DiseaseUnited Kingdom
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient Satisfaction | Mastectomy; LymphedemaHungary
-
The Netherlands Cancer InstituteMaastricht University Medical Center; Erasmus Medical Center; Ziekenhuisgroep... and other collaboratorsEnrolling by invitationAutoimmune Diseases | Breast Cancer | Breast Implant; ComplicationsNetherlands
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Integra LifeSciences CorporationUnknownBreast Neoplasms | Breast DiseasesUnited Kingdom
-
Case Comprehensive Cancer CenterWithdrawnBreast Reconstruction | MastectomyUnited States
-
West China HospitalWest China Second University Hospital; Suzhou Municipal Hospital; West China... and other collaboratorsNot yet recruiting